|
|
 |
|
MYL: Mylan Inc - Stock News |
Enter Ticker:
|
|
| Nov 20, 2009 |
Stock research report available on Mylan (NASDAQ:MYL) from SmarTrend Analytics |
| Nov 18, 2009 |
Mylan's President of Europe, Middle East and Africa Elected President of European Generic Medicines Association |
| Nov 13, 2009 |
Mylan Up 27.7% Since SmarTrend's Buy Recommendation |
| Nov 12, 2009 |
Mylan's Spanish Business Named Best Generic Pharmaceuticals Company in Spain by Elsevier |
| Nov 11, 2009 |
United States : Mylan subsidiary receives FDA approval for its Lansoprazole DR Capsules ANDA |
| Nov 11, 2009 |
Mylan Inc awarded FDA approval for generic Prevacid DR Capsules |
| Nov 10, 2009 |
Mylan Receives FDA Approval for Generic Version of Prevacid(R) Through its Subsidiary Matrix Laboratories |
| Nov 05, 2009 |
Zacks Analyst Blog Highlights: Baker Hughes Inc., BJ Services, Teva Pharmaceutical Industries Ltd., Mylan and Comcast Corp. |
| Nov 05, 2009 |
PicksThatMove.com Announces Investment Opinion On: Mylan Laboratories Inc., Suncor Energy Inc., Romarco Minerals Inc., Nord Resources Corporation and Eastern Platinum Limited |
| Nov 04, 2009 |
Mylan Laboratories (MYL) NewsBite - MYL Hits 52-Week High |
| Nov 04, 2009 |
Mylan Up 25.3% Since SmarTrend's Buy Recommendation |
| Oct 30, 2009 |
Zacks Analyst Blog Highlights: Bank of America, Citigroup, Motorola Inc., China Mobile Ltd. and Mylan, Inc. |
| Oct 29, 2009 |
Mylan Up 21.1% Since SmarTrend's Buy Recommendation |
| Oct 29, 2009 |
Mylan Laboratories Raises Guidance |
| Oct 29, 2009 |
Mylan Reports Third Quarter Adjusted Diluted EPS of $0.32 |
| |
| ZACKS COMMENTARY FOR MYL |
| Nov 13, 2009 | Zacks Blog: Another Win for Mylan | | Nov 05, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Baker Hughes Inc., BJ Services, Teva Pharmaceutical Industries Ltd., Mylan and Comcast Corp. | | Nov 04, 2009 | Zacks Blog: Teva Reports Strong Quarter | | Nov 04, 2009 | Zacks Equity Research: Report for MYL | | Oct 30, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Bank of America, Citigroup, Motorola Inc., China Mobile Ltd. and Mylan, Inc. | | Oct 29, 2009 | Zacks Blog: Mylan Beats, Raises Outlook | | Oct 15, 2009 | Zacks Blog: Mylan Settles Dispute with Pfizer | | Sep 29, 2009 | Zacks Blog: Nuvigil Granted Priority Review | | Sep 29, 2009 | Zacks Blog: Salix Hopeful on New Indications | | Sep 16, 2009 | Zacks Blog: Teva’s Copaxone Challenged | | Sep 15, 2009 | Zacks Blog: Salix Scores on Rifaximin Data | | Aug 31, 2009 | Zacks Blog: Zacks Analyst Blog Highlights: Mylan, Sanofi-Aventis, Gilead Sciences, GlaxoSmithKline and Freddie Mac |
|
|